Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”

Lignende værker

• Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
  af: Waterboer, Tim, et al.
  Udgivet: (2020)
• DRH1 – a novel blood-based HPV tumour marker
  af: Weiland, Thomas, et al.
  Udgivet: (2020)
• Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
  af: Wessely, Anja, et al.
  Udgivet: (2020)
• Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
  af: Brandon Wen Bing Chua, et al.
  Udgivet: (2022-05-01)
• Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment
  af: Zhang, Yuehan, et al.
  Udgivet: (2017)